RecruitingNCT05204017

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS


Sponsor

University of Alberta

Enrollment

150 participants

Start Date

Sep 12, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with amyotrophic lateral sclerosis, frontotemporal degeneration, and other related conditions. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(4)

University of Alberta

Edmonton, Alberta, Canada

University of Toronto / Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

McGill University / Montreal Neurological Institute and Hospital

Montreal, Quebec, Canada

CHU de Quebec -Universite de Laval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05204017


Related Trials